Persistent Ethnicity-Associated Disparity in Antitumor Effectiveness of Immune Checkpoint Inhibitors Despite Equal Access

We reviewed response to immune checkpoint inhibitors (ICI) of 207 patients with diagnoses of lung or head and neck cancer treated with chemotherapy/ICI combination therapy and ICI monotherapy between 2015 and 2020 at one of three clinical pavilions associated with the Dan L. Duncan Comprehensive Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Florez, Marcus A., Kemnade, Jan O., Chen, Nan, Du, Wendy, Sabichi, Anita L., Wang, Daniel Y., Huang, Quillan, Miller-Chism, Courtney N., Jotwani, Aparna, Chen, Albert C., Hernandez, David, Sandulache, Vlad C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367161/
https://www.ncbi.nlm.nih.gov/pubmed/35966167
http://dx.doi.org/10.1158/2767-9764.CRC-21-0143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367161/
https://www.ncbi.nlm.nih.gov/pubmed/35966167
http://dx.doi.org/10.1158/2767-9764.CRC-21-0143

Ejemplares similares